Knockdown of CMKLR1 reduces oxidative phosphorylation in oral squamous cell carcinoma, suggesting a potential therapeutic strategy.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Lin et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: